Pulmonary embolism in a 30 year-old man with chronic hepatitis C during therapy with pegylated interferon-α and ribavirin

被引：0
作者：
Elikowski, Waldemar [1 ]
Malek, Malgorzata [1 ]
Kurosz, Jolanta [2 ]
Bereszynska, Iwona [3 ]
Marszalek, Andrzej [4 ]
Zawilska, Krystyna [5 ]
Mozer-Lisewska, Iwona [4 ,6 ]
机构：
[1] Szpital J Strusia, Oddzial Chorob Wewnetrznych, PL-61285 Poznan, Poland
[2] Szpital J Strusia, Pracownia Hemostazy, PL-61285 Poznan, Poland
[3] ZOZ Poznan Stare Miasto, Poradnia Chorob Watroby, Poznan, Poland
[4] Szpital J Strusia, Oddzial Chorob Zakaznych, PL-61285 Poznan, Poland
[5] Szpital J Strusia, Oddzial Chorob Wewnetrznych & Hematol, PL-61285 Poznan, Poland
[6] Uniwersytet Med, Katedra & Klin Chorob Zakaznych, Poznan, Poland
来源：
KARDIOLOGIA POLSKA | 2010年 / 68卷 / 11期
关键词：
pulmonary embolism; interferon-alpha; ribavirin; chronic hepatitis C; VENOUS THROMBOEMBOLISM; CUTANEOUS NECROSIS; PLUS RIBAVIRIN; PATIENT; COMBINATION; INJECTION; FIBROSIS; PROTEIN; VIRUS; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The authors described a case of a 30 year-old man with chronic hepatitis C (G1,S1) complicated by pulmonary embolism (PE), preceded by symptoms of respiratory system infection, which occurred after 6 months of combination therapy with pegylated interferon-a and ribavirin. Right sided nonbacterial thrombotic endocarditis as a source of segmental/subsegmental PE was found. Hemostatic work up showed increased activated protein C resistance, elevated factor VIII activity and fibrinogen concentration as well as hyperhomocysteinaemia (all these disturbances returned to normal 3-6 months later). The patient's clinical status improved during anticoagulation therapy. Antiviral treatment was not continued as virological response was achieved.
引用
收藏
页码：1261 / 1265
页数：5
相关论文
共 50 条
  • [31] Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
    Espinosa, Mario
    Hernandez, Jesus
    Dolores Arenas, Maria
    Carnicer, Fernando
    Caramelo, Carlos
    Fabrizi, Fabrizio
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2015, 40 (03) : 258 - 265
  • [32] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [33] Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C
    Seyam, MS
    Freshwater, DA
    O'Donnell, K
    Mutimer, DJ
    [J]. JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) : 531 - 535
  • [34] Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-α and ribavirin
    Takaki, Shintaro
    Kawakami, Yoshiiku
    Imamura, Michio
    Aikata, Hiroshi
    Takahashi, Shoichi
    Ishihara, Hiroto
    Tsuji, Keiji
    Aimitsu, Shiomi
    Kawakami, Hiroiku
    Nakanishi, Toshio
    Kitamoto, Mikiya
    Moriya, Takashi
    Satoh, Kenichi
    Chayama, Kazuaki
    [J]. INTERVIROLOGY, 2007, 50 (06) : 439 - 446
  • [35] Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy
    Wang, X.
    Gao, F.
    Yuan, G.
    Shi, K.
    Huang, Y.
    Chen, Y.
    Qiu, R.
    Sun, L.
    Liu, J.
    Hu, C.
    Zhou, Y.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2016, 23 (12) : 971 - 976
  • [36] CORRELATION BETWEEN BIOCHEMICAL AND HISTOPATHOLOGICAL PARAMETERS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Karin, Maja
    Bevanda, Milenko
    Babic, Emil
    Mimica, Mladen
    Bevanda-Glibo, Daniela
    Volaric, Mile
    Bogut, Ante
    Pravdic, Danijel
    [J]. PSYCHIATRIA DANUBINA, 2014, 26 : 8 - 13
  • [37] Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin
    Ridruejo, Ezequiel
    Christensen, Alejo Florin
    Mando, Oscar G.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 693 - 694
  • [38] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    [J]. World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [39] Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea
    Kim, Hyeong Il
    Kim, In Hee
    Jeon, Byung Jun
    Lee, Seok
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    [J]. HEPATITIS MONTHLY, 2012, 12 (07) : 430 - 436
  • [40] Hepatitis C virus kinetics during the first phase of pegylated interferon-α-2b with ribavirin therapy in patients with living donor liver transplantation
    Ichikawa, Tatsuki
    Nakao, Kazuhiko
    Miyaaki, Hisamitsu
    Eguchi, Susumu
    Takatsuki, Mitsuhisa
    Fujimito, Masumi
    Akiyama, Motohisa
    Miuma, Satoshi
    Ozawa, Eisuke
    Shibata, Hidetaka
    Takeshita, Shigeyuki
    Kanematsu, Takashi
    Eguchi, Katsumi
    [J]. HEPATOLOGY RESEARCH, 2009, 39 (09) : 856 - 864
12345